The liquid biopsy in breast cancer is a non-invasive blood test that analyzes the circulating tumour DNA (ctDNA) released by neoplastic cells. According to the Italian Association of Medical Oncology, it is a key tool in precision oncology, with benefits for patients and clinicians. The advantages for patients are undeniable, it allows us to intercept any therapeutic targets, i.e. mutations that can appear also during the course of the disease, …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Liquid biopsy in breast cancer is a non-invasive blood test that analyzes the circulating tumor DNA (ctDNA) released by neoplastic cells. According to the indications of the Italian Association of Medical Oncology, it represents a key tool in precision oncology, with benefits for patients and clinicians. “The advantages for patients are undeniable, it allows us [...]
The Berardi article (AIOM): “” Liquid biopsy for breast cancer essential to ide…
(Adnkronos) - Liquid biopsy in breast cancer is a non-invasive blood test that analyzes circulating tumour DNA (ctDNA) released from neoplastic cells. According to the Association's indications...